Evolent director granted 41,096 RSUs
Springstubb Brendan B reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Springstubb Brendan B reported acquisition or exercise transactions in this Form 4 filing.
Evolent Health, Inc. director Brendan B. Springstubb received a grant of 41,096 shares of Class A Common Stock in the form of restricted stock units at a price of $0.00 per share. Following this equity award, he holds 99,917 shares directly. The restricted stock units were granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan and will vest on the earlier of June 4, 2027, or the company’s 2027 annual meeting, subject to his continued service.
Insider Trade Summary
Grant/Award: 41,096 shares
Grant/Award
1 txn
Insider
Springstubb Brendan B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 41,096 | $0.00 | $0.00 |
Holdings After Transaction:
Class A Common Stock — 99,917 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units granted to Mr. Springstubb pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- F2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
Key Figures
RSU grant size: 41,096 shares
Grant price per share: $0.00 per share
Total shares after grant: 99,917 shares
+2 more
5 metrics
RSU grant size
41,096 shares
Restricted stock units of Class A Common Stock granted to director
Grant price per share
$0.00 per share
Reported transaction price for RSU award
Total shares after grant
99,917 shares
Brendan B. Springstubb’s direct holdings following the transaction
Vesting date
June 4, 2027
Latest possible vesting date, or earlier 2027 annual meeting
Transaction code
A
Grant, award, or other acquisition of non-derivative securities
Key Terms
restricted stock units, Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan, vest, annual meeting
4 terms
restricted stock units financial
"Represents restricted stock units granted to Mr. Springstubb pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan financial
"Represents restricted stock units granted to Mr. Springstubb pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
vest financial
"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting regulatory
"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Evolent Health (EVH) report for Brendan Springstubb?
Evolent Health reported that director Brendan B. Springstubb received 41,096 restricted stock units of Class A Common Stock. The grant is a stock-based compensation award with no cash paid per share and is tied to future vesting conditions and continued service.
What type of equity award did Evolent Health (EVH) grant to Brendan Springstubb?
Brendan B. Springstubb received restricted stock units representing 41,096 shares of Evolent Health Class A Common Stock. These awards were made under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan as part of his compensation as a director.
When do Brendan Springstubb’s Evolent Health (EVH) restricted stock units vest?
The restricted stock units granted to Brendan B. Springstubb vest on the earlier of June 4, 2027, or the date of Evolent Health’s 2027 annual meeting. Vesting is contingent on his continued service with the company through the applicable vesting date.
Under which plan were the Evolent Health (EVH) restricted stock units granted?
The restricted stock units for 41,096 shares were granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. This plan governs stock-based compensation awards to eligible participants, including directors such as Brendan B. Springstubb.
AI-generated analysis. How Rhea-AI works. Not financial advice.
